Kristin Klesko
Analyst
Cantor
Equibles does not estimate personal net worth.
About Kristin Klesko
Kristin Klesko is recorded as Analyst at Cantor. Kristin Klesko has spoken on 1 earnings call across 1 company, most recently for Fulcrum Therapeutics, Inc. on April 27, 2026. The companies whose calls Kristin Klesko spoke on are classified in the Healthcare sector.
Kristin Klesko on recent calls
“And let me also add my congrats to Allen for a great career in biotech and pharma, including the accomplishments at Fulcrum. The first question I had for you was just on broadly understanding the latest views coming from FDA.”
Affiliation history
-
Cantor
Analyst
Transcript header (unverified)
Current